NASDAQ: PBYI
Puma Biotechnology Inc Stock Ownership - Who owns Puma Biotechnology?

Insider buying vs selling

Have Puma Biotechnology Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Douglas M. HuntOfficer2025-01-028,633$3.15
$27.21kSell
Jeffrey Jerome LudwigChief Commercial Officer2025-01-029,437$3.15
$29.75kSell
Alan H. AuerbachPresident and CEO2025-01-0233,841$3.15
$106.67kSell
Maximo F. NouguesChief Financial Officer2025-01-0210,227$3.15
$32.24kSell
Michael Patrick MillerDirector2024-08-1223,358$3.49
$81.47kSell
Douglas M. HuntOfficer2024-07-173,637$3.70
$13.46kSell
Maximo F. NouguesChief Financial Officer2024-07-174,156$3.70
$15.38kSell
Jeffrey Jerome LudwigChief Commercial Officer2024-07-172,598$3.70
$9.62kSell
Alan H. AuerbachPresident and CEO2024-07-1721,920$3.70
$81.13kSell
Jeffrey Jerome LudwigChief Commercial Officer2024-07-026,051$3.27
$19.77kSell

1 of 2

PBYI insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when PBYI insiders and whales buy or sell their stock.

PBYI Shareholders

What type of owners hold Puma Biotechnology Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Adage Capital Partners GP LLC17.89%8,879,139$29.75MInsider
Alan H. Auerbach14.56%7,228,073$24.21MInsider
Acorn Capital Advisors LLC7.94%3,940,052$13.20MInstitution
Blackrock Inc7.75%3,847,368$12.89MInstitution
Vanguard Group Inc7.39%3,669,263$12.29MInstitution
Adage Capital Partners LP6.45%3,200,000$10.72MInsider
Acadian Asset Management LLC4.05%2,008,146$6.73MInstitution
Renaissance Technologies LLC3.69%1,829,213$6.13MInstitution
Millennium Management LLC2.79%1,385,194$4.64MInstitution
American Century Companies Inc2.32%1,149,660$3.85MInstitution

1 of 3

PBYI vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
PBYI58.13%41.87%Net Selling
ALDX63.26%27.92%Net SellingNet Selling
SLS14.32%8.68%Net BuyingNet Buying
CYBN39.14%0.00%
EDIT52.57%39.39%Net SellingNet Selling

Puma Biotechnology Stock Ownership FAQ

Who owns Puma Biotechnology?

Puma Biotechnology (NASDAQ: PBYI) is owned by 61.27% institutional shareholders, 44.13% Puma Biotechnology insiders, and 0.00% retail investors. Adage Capital Partners GP LLC is the largest individual Puma Biotechnology shareholder, owning 8.88M shares representing 17.89% of the company. Adage Capital Partners GP LLC's Puma Biotechnology shares are currently valued at $29.75M.

If you're new to stock investing, here's how to buy Puma Biotechnology stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.